Hong Ji

Hong Ji has a strong background in analytical development and quality control within the pharmaceutical industry. They most recently served as the Director of Analytical Development and Quality Control at Neumora since May 2021. Prior to that, Hong Ji worked at Mirum Pharmaceuticals as an Associate Director of ADQC from December 2019 to May 2021. They also had extensive experience at Relypsa, starting as a Scientist I/II in May 2013 and progressing to roles such as Staff Scientist I/II, Group Leader, and Associate Director of QC. During their time at Relypsa, Hong Ji led various projects, including new vendor selection, stability studies, and cost-reduction process improvement projects. They were responsible for organizing the AD/QC group to respond to MAA requests and led activities to support the EU approval and launch. Before Relypsa, Hong Ji worked at LS9, Inc. as a Scientist I/II, where they focused on lipid characterization, quantitation assays, cell physiology studies, and assay development. They demonstrated expertise in analytical techniques such as GC/MS, NMR, LC/MS/MS, SDS-PAGE gel analysis, and mass spectrometry.

Hong Ji has a Ph.D. in Chemistry from Oregon State University. Prior to that, Hong Ji obtained a Bachelor of Science degree in Chemistry from Nanjing University.